OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CYP2D6 Phenotype Influences Aripiprazole Tolerability in Pediatric Patients with Mood Disorders
Sahar A. Jallaq, Mark Verba, Jeffrey R. Strawn, et al.
Journal of Child and Adolescent Psychopharmacology (2020) Vol. 31, Iss. 1, pp. 56-62
Open Access | Times Cited: 13
Sahar A. Jallaq, Mark Verba, Jeffrey R. Strawn, et al.
Journal of Child and Adolescent Psychopharmacology (2020) Vol. 31, Iss. 1, pp. 56-62
Open Access | Times Cited: 13
Showing 13 citing articles:
Pharmacogenomics: A road ahead for precision medicine in psychiatry
Antonio F. Pardiñas, Michael J. Owen, James Walters
Neuron (2021) Vol. 109, Iss. 24, pp. 3914-3929
Open Access | Times Cited: 41
Antonio F. Pardiñas, Michael J. Owen, James Walters
Neuron (2021) Vol. 109, Iss. 24, pp. 3914-3929
Open Access | Times Cited: 41
Influence of CYP2C19 and CYP2D6 on side effects of aripiprazole and risperidone: A systematic review
Emma Y De Brabander, Kristian Kleine Schaars, Thérèse van Amelsvoort, et al.
Journal of Psychiatric Research (2024) Vol. 174, pp. 137-152
Open Access | Times Cited: 6
Emma Y De Brabander, Kristian Kleine Schaars, Thérèse van Amelsvoort, et al.
Journal of Psychiatric Research (2024) Vol. 174, pp. 137-152
Open Access | Times Cited: 6
CYP2D6 pharmacogenetics and phenoconversion in personalized medicine
Noor A. Nahid, Julie A. Johnson
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 11, pp. 769-785
Closed Access | Times Cited: 22
Noor A. Nahid, Julie A. Johnson
Expert Opinion on Drug Metabolism & Toxicology (2022) Vol. 18, Iss. 11, pp. 769-785
Closed Access | Times Cited: 22
The Implications of Cytochrome P450 2D6/CYP2D6 Polymorphism in the Therapeutic Response of Atypical Antipsychotics in Adolescents with Psychosis—A Prospective Study
Adriana Cojocaru, Adina Braha, Roxana Maria Jeleriu, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 494-494
Open Access | Times Cited: 4
Adriana Cojocaru, Adina Braha, Roxana Maria Jeleriu, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 494-494
Open Access | Times Cited: 4
The pharmacogenetics of the new-generation antipsychotics – A scoping review focused on patients with severe psychiatric disorders
Octavian Vasiliu
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 10
Octavian Vasiliu
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 10
CYP2D6 Genetic Variation and Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis
Yanisa Wannasuphoprasit, Stig Ejdrup Andersen, María J. Arranz, et al.
Frontiers in Psychology (2022) Vol. 12
Open Access | Times Cited: 11
Yanisa Wannasuphoprasit, Stig Ejdrup Andersen, María J. Arranz, et al.
Frontiers in Psychology (2022) Vol. 12
Open Access | Times Cited: 11
Letter to the Editor: Aripiprazole-Induced Hypersexuality in an Autistic Child
Joshua R. Smith, Donald Pierce
Journal of Child and Adolescent Psychopharmacology (2022) Vol. 32, Iss. 1, pp. 70-71
Closed Access | Times Cited: 4
Joshua R. Smith, Donald Pierce
Journal of Child and Adolescent Psychopharmacology (2022) Vol. 32, Iss. 1, pp. 70-71
Closed Access | Times Cited: 4
Evaluation of SLCA62 and CYP2D6 Polymorphisms’ Effects on Atomoxetine Treatment in Attention Deficit and Hyperactivity Disorder
İsmail Hasan Köle, Pınar IRMAK VURAL, Beste Yurdacan, et al.
Research Square (Research Square) (2024)
Open Access
İsmail Hasan Köle, Pınar IRMAK VURAL, Beste Yurdacan, et al.
Research Square (Research Square) (2024)
Open Access
Evaluation of SLC6A2 and CYP2D6 polymorphisms’ effects on atomoxetine treatment in attention deficit and hyperactivity disorder
İsmail Hasan Köle, Pınar IRMAK VURAL, Beste Yurdacan, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 11, pp. 1773-1785
Closed Access
İsmail Hasan Köle, Pınar IRMAK VURAL, Beste Yurdacan, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 11, pp. 1773-1785
Closed Access
Getting to Precision Psychopharmacology in Child Psychiatry: The Value of Adverse Treatment Effects
Ginger E. Nicol, Iliyan Ivanov
Journal of Child and Adolescent Psychopharmacology (2021) Vol. 31, Iss. 1, pp. 1-3
Closed Access | Times Cited: 3
Ginger E. Nicol, Iliyan Ivanov
Journal of Child and Adolescent Psychopharmacology (2021) Vol. 31, Iss. 1, pp. 1-3
Closed Access | Times Cited: 3
The need for a refined understanding of CYP2D6 in second-generation antipsychotic outcomes in children and adolescents
Katelyn M. Rossow, Samuel Vaughn, Jeffrey R. Strawn, et al.
Pharmacogenomics (2021) Vol. 22, Iss. 8, pp. 447-450
Closed Access | Times Cited: 2
Katelyn M. Rossow, Samuel Vaughn, Jeffrey R. Strawn, et al.
Pharmacogenomics (2021) Vol. 22, Iss. 8, pp. 447-450
Closed Access | Times Cited: 2
Is the CYP2D6 Genotype Associated with Antipsychotic-Induced Weight Gain?
Gesche Jürgens, Benjamin Skov Kaas‐Hansen, Merete Nordentoft, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1728-1728
Open Access | Times Cited: 1
Gesche Jürgens, Benjamin Skov Kaas‐Hansen, Merete Nordentoft, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1728-1728
Open Access | Times Cited: 1
De impact van CYP2D6-polymorfisme op een behandeling met aripiprazol bij kinderen en jongeren: een systematische review
E. Raskin, Marina Danckaerts
Tijdschrift voor Geneeskunde (2022)
Closed Access
E. Raskin, Marina Danckaerts
Tijdschrift voor Geneeskunde (2022)
Closed Access
